MCE 的所有产品仅用作科学研究，我们不为任何个人用途提供产品和服务。

Thapsigargin

CAS No. : 67526-95-8

MCE 站：Thapsigargin

产品活性：Thapsigargin 是一种微粒体 Ca²⁺-ATPase 抑制剂。Thapsigargin 是一种表征良好的内质网应激诱导剂。

研究领域：Membrane Transporter/Ion Channel  |  Neuronal Signaling  |  Apoptosis

作用靶点：Calcium Channel  |  Apoptosis

In Vitro: Thapsigargin (0.001-?1 μM; for 2 and 4 days) arrests cell proliferations in MH7A human rheumatoid arthritis synovial cells in a time- and dose-dependent manner.
Thapsigargin (0.001-?1 μM; for 2 and 4 days) induces cell apoptosis in MH7A cells in a time- and dose-dependent manner.
Thapsigargin (0.001-?1 μM; for 2 and 4 days) impairs mTOR activity and leads to cyclin D1 expressions in MH7A cells.
Thapsigargin inhibits Ca²⁺ entry into human neutrophil granulocytes.
Thapsigargin inhibits the carbachol-evoked [Ca²⁺]i-transients with (IC₅₀=0.353 nM) or without (IC₅₀=0.448 nM) a KCl-prestimulation, but an additional small component, with a much lower sensitivity (IC₅₀=4814 nM), is observed in the absence of a KCl-prestimulation. In contrast, the KCl-evoked [Ca²⁺]i-transients displayed only one component with a very low sensitivity to Thapsigargin in both absence (IC₅₀=3343 nM) and presence (IC₅₀=6858 nM) of a carbachol-prestimulation.

In Vivo: Thapsigargin (Injection; 0.25 ug/g, 0.5 ug/g and 1 ug/g; 24 hours) significant increases of 2 to 5-fold in chemokine and pro-inflammatory expression. Thapsigargin is more sensitive to inducing a systemic immune response.

相关产品：Bioactive Compound Library Plus  |  MG-132  |  LY294002  |  Actinomycin D  |  Mitomycin C  |  Doxorubicin hydrochloride  |  Bafilomycin A1  |  Paclitaxel  |  Y-27632 dihydrochloride  |  SP600125  |  Sorafenib  |  Angiotensin II human  |  MK-2206 dihydrochloride  |  5-Fluorouracil  |  Trametinib  |  Bortezomib  |  Tamoxifen  |  Gemcitabine  |  Pexidartinib  |  Acetylcysteine  |  Decitabine  |  BAY 11-7082  |  2-Deoxy-D-glucose  |  Temozolomide  |  Docetaxel  |  Dasatinib  |  Verteporfin  |  Ruxolitinib  |  Etoposide  |  Everolimus

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。